白云山(00874.HK)调整收购广州医药30%股权事项的独立财务顾问主办人
格隆汇8月2日丨白云山(00874.HK)公布,中信证券为公司2018年度向Alliance BMP Limited购买其所持有广州医药30%股权的独立财务顾问,该重大资产重组已顺利实现资产交割,目前处于持续督导期。中信证券根据规定担任持续督导机构,原委派吕斌和郭卓然为此次重大资产重组独立财务顾问主办人。
公司近日收到中信证券《关于广州白云山医药集团股份有限公司重大资产重组项目独立财务顾问主办人调整的说明》,因吕斌已不在中信证券任职,无法继续作为此次重大资产重组项目的财务顾问主办人履行相应职责,中信证券决定吕斌不再担任该项目的财务顾问主办人,陈枢接替担任该项目的财务顾问主办人。此次调整后,中信证券关于此次重大资产重组项目的独立财务顾问主办人为郭卓然和陈枢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.